Yield10 Bioscience, Inc. (YTEN) Reports Q1 Loss of $0.24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Yield10 Bioscience Announces First Quarter 2018 Financial Results
May 10, 2018 4:05 PM EDTWOBURN, Mass., May 10, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today reported financial results for the three months ended March 31, 2018.
In the first quarter, our team was focused on executing activities needed to enable the start of our 2018 Field Tests in Canada and the U.S., said Oliver P. Peoples, Ph.D., President and Chief Executive Officer of Yield10 Bioscience. In our field tests we will evaluate versions of our second generation C3003 in... More
